\u003ci\u003ePharmacogenomics: Challenges and Opportunities in Therapeutic Implementation, Second Edition\u003c/i\u003e, provides comprehensive coverage of the challenges and opportunities facing the therapeutic implications of pharmacogenomics from academic, regulatory, pharmaceutical, socio-ethical and economic perspectives. While emphasis is on the limitations in moving the science into drug development and direct therapeutic applications, this book also focuses on clinical areas with successful applications and important initiatives that have the ability to further advance the discipline. New chapters cover important topics such as pharmacogenomic data technologies, clinical testing strategies, cost-effectiveness, and pharmacogenomic education and practice guidelines. The importance of ethnicity is also discussed, which highlights phar,acogenomic diversity across Latin American populations.\u003cbr\u003e\u003cbr\u003eWith chapters written by interdisciplinary experts and insights into the future direction of the field, this book is an indispensable resource for academic and industry scientists, graduate students and clinicians engaged in pharmacogenomics research and therapeutic implementation.\u003cul\u003e \u003cli\u003eProvides viewpoints that focus on the scientific and translational challenges and opportunities associated with advancing the field of pharmacogenomics\u003c/li\u003e \u003cli\u003eHighlights progress in both the research and clinical areas of pharmacogenomics, as well as relevant implementation experience, challenges, and perspectives on direct-to-consumer genetic testing\u003c/li\u003e \u003cli\u003eIncludes, where applicable, discussion points, review questions, and cases for self-assessment purposes and to facilitate in-depth discussion\u003c/li\u003e\u003c/ul\u003e
nl
en
